Ad is loading...
MENU
FRBRX
Mutual Fund ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

FRBRX price forecast, quote, news & analysis

Category: @Health
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB), Intra-Cellular Therapies (NASDAQ:ITCI).

Industry description

The investment seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The fund predominantly invests in equity securities. In addition to its investments in biotechnology companies, the fund may also invest up to 20% of its net assets in equity or debt securities of any type of issuer. It is non-diversified.

Market Cap

The average market capitalization across the Franklin Biotechnology Discovery R6 MF is 78.67B. The market cap for tickers in the group ranges from 6.7B to 208.98B. AZN holds the highest valuation in this group at 208.98B. The lowest valued company is ITCI at 6.7B.

Volume

The average weekly volume growth across all stocks in the Franklin Biotechnology Discovery R6 MF was -42%. For the same stocks of the MF, the average monthly volume growth was -46% and the average quarterly volume growth was -49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 69
Price Growth Rating: 51
SMR Rating: 68
Profit Risk Rating: 45
Seasonality Score: 40 (-100 ... +100)
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Franklin Strategic SeriesOne Franklin ParkwaySan Mateo
Phone
N/A
Web
www.franklintempleton.com